what percentage of people are on glp 1 Products - Data Briefs - Number 537 GLP-1 trends 2025: real-world data,

Designed specifically for men looking to push their limits, this powerful supplement supports your metabolism while helping you stay focused and energized throughout your day and workouts

In 2014, the US Food and Drug Administration approved the first glucagon-like peptide-1 (GLP-1) receptor agonist product, liraglutide injection, for obesity treatment

GLP-1 receptor agonists are not recommended during pregnancy due to limited human safety data and animal study findings

This can lead to rapid weight lossin some cases, up to 20 percent of your body weight

Hypoallergenic and Non-GMO

/PRNewswire/ -- GNC, the global leader in health and wellness, today announced its unprecedented initiative to support individuals using GLP-1 agonists